Icon, the Dublin-based clinical trials group for pharmaceutical manufacturers globally, said that it overstated revenues by ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Q1 2026 Management View "ICON's results in quarter 1 were in line with our expectations and reflected sustained progress in commercial performance alongside the expected impacts of previous demand and ...

ICON plc delivered mixed 4Q25 results: EPS missed by $0.22, but revenue beat by $170M, highlighting margin pressure amid strong demand. FY26 guidance signals a transition year, with revenue expected ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Earnings Call Insights: ICON Public Limited Company (ICLR) Q2 2025 Full-year revenue guidance was updated to a new range of $7.85 billion at the low end and $8.15 billion at the high end, "increasing ...

“ICON maintained strong commercial momentum in quarter one, delivering net bookings of $2.9B, and a net book-to-bill of 1.42, ...

Icon's stock jumped nearly 11% on June 24 after it reported first-quarter results highlighted by net business wins of nearly $2.9 billion and a net book/bill ratio of 1.42 times. First-quarter revenue ...